Company: IMNN
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001493152-25-011598
Chunk: 0

Company: Imunon, Inc.
Filing Date: 2025-08-05
Form: 10-Q
Item: Part II, Item 1A
Chunk 0
---
With
the exception of the changes described and set forth below, there have been no material changes to our risk factors from those disclosed
under “Risk Factors” in Part I, Item 1A of our 2024 Annual Report on Form 10-K. The risks and uncertainties described in
our 2024 Annual Report on Form 10-K, as supplemented by this Form 10-Q, are not the only ones we face. Additional risks and uncertainties
not presently known to us or that we currently deem immaterial may also materially adversely affect our business, financial condition,
or results of operations.

Risks
Related Investing in our Common Stock

Any
market activity involving short selling or other market making activities could result in negative impact to the market price for our
Common Stock.

Short
selling is a method used to capitalize on an expected decline in the market price of a security and could depress the price of our Common
Stock, which could further increase the potential for future short sales. Sales of our Common Stock could encourage short sales by market
participants, which could create negative market momentum. Continued short selling may bring about a temporary, or possibly long term,
decline in the market price of our Common Stock. The Company cannot predict the size of future issuances or sales of Common Stock or
the effect, if any, that future issuances and sales of Common Stock will have on its market price or the activities of short sellers.
Sales involving significant amounts of Common Stock, including issuances made in the ordinary course of the Company’s business,
or the perception that such sales could occur, may materially and adversely affect prevailing market prices of the Common Stock.

Our
Common Stock may be delisted from Nasdaq if we fail to comply with continued listing standards.

Our
Common Stock is currently traded on Nasdaq under the symbol “IMNN.” If we fail to comply with Nasdaq’s continued listing
standards, we may be delisted and our Common Stock will trade, if at all, only on the over-the-counter market, such as the OTC Bulletin
Board or OTCQX market, and then only if one or more registered broker-dealer market makers comply with quotation requirements. In addition,
delisting of our Common Stock could depress our stock price, substantially limit liquidity of our Common Stock and materially adversely
affect our ability to raise capital on terms acceptable to us, or at all. Further, delisting of our Common Stock would likely result
in our Common Stock becoming a “penny stock”